A recent paper by Guo et al. [90] using transcriptional analysis demonstrated that KD improves hepatic steatosis via FGF21 and its receptor klotho (KLB) pathway activation in a murine model, confirming the crucial role of the FGF21 pathway in hepatic fat reduction during KD [91]. The gene discussed is FGF21; the disease is fatty liver disease.